The PE Ratio as of December 2024 (TTM) for Lixte Biotechnology Holdings, Inc. (LIXT) is -1.21

According to Lixte Biotechnology Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.21. This represents a change of -15.72% compared to the average of -1.44 of the last 4 quarters.

Lixte Biotechnology Holdings, Inc. (LIXT) Historical PE Ratio (quarterly & annually)

How has LIXT PE Ratio performed in the past?

The mean historical PE Ratio of Lixte Biotechnology Holdings, Inc. over the last ten years is -2.47. The current -1.21 PE Ratio has changed 4.81% with respect to the historical average. Over the past ten years (40 quarters), LIXT's PE Ratio was at its highest in in the September 2015 quarter at -0.39. The PE Ratio was at its lowest in in the December 2020 quarter at -10.12.

Lixte Biotechnology Holdings, Inc. (LIXT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lixte Biotechnology Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lixte Biotechnology Holdings, Inc. (LIXT) Average PE Ratio

How has LIXT PE Ratio performed in the past?

The current PE Ratio of Lixte Biotechnology Holdings, Inc. (LIXT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lixte Biotechnology Holdings, Inc. (LIXT) PE Ratio vs. Peers

How is LIXT’s PE Ratio compared to its peers?

Lixte Biotechnology Holdings, Inc.’s PE Ratio is less than Allarity Therapeutics, Inc. (-0.08), less than NeuroBo Pharmaceuticals, Inc. (-0.87), less than Hillstream BioPharma, Inc. (-0.99), less than Virax Biolabs Group Limited (-0.58), less than Quoin Pharmaceuticals, Ltd. (-0.28), less than Indaptus Therapeutics, Inc. (-0.60), less than Pasithea Therapeutics Corp. (-0.17), less than Kiromic BioPharma, Inc. (-1.13), less than Biodexa Pharmaceuticals Plc (-0.16), greater than PMV Pharmaceuticals, Inc. (-1.47), greater than Olema Pharmaceuticals, Inc. (-2.97), greater than Enochian Biosciences, Inc. (-1.62), greater than Scholar Rock Holding Corporation (-19.60), less than Passage Bio, Inc. (-0.58),

Build a custom stock screener for Lixte Biotechnology Holdings, Inc. (LIXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lixte Biotechnology Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lixte Biotechnology Holdings, Inc. (LIXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lixte Biotechnology Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.